Search details
1.
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
J Virol
; 96(9): e0038922, 2022 05 11.
Article
in English
| MEDLINE | ID: mdl-35412347
2.
The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice.
Vaccines (Basel)
; 11(10)2023 Oct 11.
Article
in English
| MEDLINE | ID: mdl-37896985
3.
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses.
Emerg Microbes Infect
; 12(1): 2192821, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-36927227
4.
DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice.
Front Immunol
; 14: 1020134, 2023.
Article
in English
| MEDLINE | ID: mdl-37006299
5.
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Front Immunol
; 13: 1050250, 2022.
Article
in English
| MEDLINE | ID: mdl-36713447
6.
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1.
Vaccines (Basel)
; 9(8)2021 Aug 04.
Article
in English
| MEDLINE | ID: mdl-34451977
7.
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages.
iScience
; 24(11): 103328, 2021 Nov 19.
Article
in English
| MEDLINE | ID: mdl-34805790
8.
DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model.
Front Immunol
; 12: 785349, 2021.
Article
in English
| MEDLINE | ID: mdl-35095861
9.
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity.
Expert Opin Biol Ther
; 20(9): 1083-1097, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32297534
Results
1 -
9
de 9
1
Next >
>>